09.11.17
Tel Aviv, Israel
www.avgol.com
2017 Nonwoven Sales $367 million
Key Personnel
David Meldram, CEO; Shachar Rachim, deputy CEO; Gilad Frenkel, vice president of sales and marketing, Soren Lian, APAC sales director; Thomas Dort, vice president of technology
Plants
Israel, North Carolina, China, Russia, India
Major Markets
Hygiene, medical
Israel’s largest nonwovens producer, Avgol, has been acquired by multinational chemical producer, Indorama Ventures Spain SL. The private corporation, affiliated with Indorama Ventures Public Company Ltd, part of the Indorama Ventures Group, acquired a 65.72% stake in Avgol in July this year.
Indorama Ventures is already the owner of a number of nonwovens industry raw material suppliers including Fibervisions, Wellman International and Trevira.
“We are excited by the unique opportunity to bring Avgol into the Indorama Ventures family as it is a major step into expanding our HVA portfolio,” says group CEO Aloke Lohia. “With this acquisition, we are adding a company that has a distinctive position within a compelling segment and with strong growth prospects. Avgol has already made some significant investments to grow the business by expanding its production capacity and geographical footprint and we hope to capture the benefits and help the company reach further heights. Avgol’s established client base, complementary capabilities and substantial presence in high-growth markets, together with Indorama Ventures’ global presence, will provide a strong opportunity for creating additional value to best serve all of our customers.”
With existing operations in North Carolina, Russia, Israel and China, Avgol’s latest frontier is India where it recently completed work on a spunmelt line for local hygiene markets. The investment is the first non-Reicofil line in operation by the company.
“For Avgol, to get into India was a very exciting development,” says David Meldram, CEO. “We started to explore the opportunity to operate in India six years ago and we waited until the right time to execute. We hope it is the first of many investments in India.”
A combination of a strong birth rate—with 20 million babies being born annually—and government incentives for product development, India is rapidly becoming a strong growth market for baby diapers and other hygiene products.
Approximately 97% of Avgol’s business is in the hygiene market, where the company says it is very passionate about quality. This passion has guided Avgol in leading an industry-wide effort to decrease the weights of core wrapping materials to 7 gsm.
“We aim to be a creative partner of choice for our strategic customers to develop the next generation of products and deploy them globally,” says Tom Dort, vice president of technology. “Research and development is at the heart of everything we do.”
This spring, Avgol introduced Waveform 3D technology, a unique process which modifies nonwoven fabrics for hygiene applications. The technology enables varying three-dimensional composition within flat fabrics, providing enhanced performance and comfort. The technology imparts beneficial fiber structures with decisive surface patterns to provide benefits like advanced skin wellness, increased cushioning and enhanced cotton feel.
Additionally, its beneFIT Control antimicrobial solution was launched at ANEX 2018. This tailor-made, next-generation technology has been developed to aid in contamination, discomfort and odor by controlling the microbial activity within hygiene applications, including diapers, adult incontinence and feminine care.
beneFIT Control is part of the beneFIT family of functional skin wellness technologies, a new range of chemistries and processes developed by Avgol to deliver superior performance and comfort to consumers. beneFIT Control can be used in tandem with other of Avgol’s FIT technologies to enhance functionality even further.
Described as an adaptable solution to infection, contamination and spoilage in healthcare settings, beneFIT Control has a unique ability to minimize the impact on natural and normal skin flora while maximizing effect on troublesome organisms. Most other antimicrobial technologies are not selective in their function, resulting in all the microbials being killed or limited all the time.
beneFIT Control technology has been designed with the disposable hygiene product specifically in mind. During testing, beneFIT Control has demonstrated multiple advantages in comparison to conventional solutions. Fabrics utilizing the new technology provide a fast response ideal for the short duration of use that hygiene products typically have and retains a bright white appearance desired by consumers.
www.avgol.com
2017 Nonwoven Sales $367 million
Key Personnel
David Meldram, CEO; Shachar Rachim, deputy CEO; Gilad Frenkel, vice president of sales and marketing, Soren Lian, APAC sales director; Thomas Dort, vice president of technology
Plants
Israel, North Carolina, China, Russia, India
Major Markets
Hygiene, medical
Israel’s largest nonwovens producer, Avgol, has been acquired by multinational chemical producer, Indorama Ventures Spain SL. The private corporation, affiliated with Indorama Ventures Public Company Ltd, part of the Indorama Ventures Group, acquired a 65.72% stake in Avgol in July this year.
Indorama Ventures is already the owner of a number of nonwovens industry raw material suppliers including Fibervisions, Wellman International and Trevira.
“We are excited by the unique opportunity to bring Avgol into the Indorama Ventures family as it is a major step into expanding our HVA portfolio,” says group CEO Aloke Lohia. “With this acquisition, we are adding a company that has a distinctive position within a compelling segment and with strong growth prospects. Avgol has already made some significant investments to grow the business by expanding its production capacity and geographical footprint and we hope to capture the benefits and help the company reach further heights. Avgol’s established client base, complementary capabilities and substantial presence in high-growth markets, together with Indorama Ventures’ global presence, will provide a strong opportunity for creating additional value to best serve all of our customers.”
With existing operations in North Carolina, Russia, Israel and China, Avgol’s latest frontier is India where it recently completed work on a spunmelt line for local hygiene markets. The investment is the first non-Reicofil line in operation by the company.
“For Avgol, to get into India was a very exciting development,” says David Meldram, CEO. “We started to explore the opportunity to operate in India six years ago and we waited until the right time to execute. We hope it is the first of many investments in India.”
A combination of a strong birth rate—with 20 million babies being born annually—and government incentives for product development, India is rapidly becoming a strong growth market for baby diapers and other hygiene products.
Approximately 97% of Avgol’s business is in the hygiene market, where the company says it is very passionate about quality. This passion has guided Avgol in leading an industry-wide effort to decrease the weights of core wrapping materials to 7 gsm.
“We aim to be a creative partner of choice for our strategic customers to develop the next generation of products and deploy them globally,” says Tom Dort, vice president of technology. “Research and development is at the heart of everything we do.”
This spring, Avgol introduced Waveform 3D technology, a unique process which modifies nonwoven fabrics for hygiene applications. The technology enables varying three-dimensional composition within flat fabrics, providing enhanced performance and comfort. The technology imparts beneficial fiber structures with decisive surface patterns to provide benefits like advanced skin wellness, increased cushioning and enhanced cotton feel.
Additionally, its beneFIT Control antimicrobial solution was launched at ANEX 2018. This tailor-made, next-generation technology has been developed to aid in contamination, discomfort and odor by controlling the microbial activity within hygiene applications, including diapers, adult incontinence and feminine care.
beneFIT Control is part of the beneFIT family of functional skin wellness technologies, a new range of chemistries and processes developed by Avgol to deliver superior performance and comfort to consumers. beneFIT Control can be used in tandem with other of Avgol’s FIT technologies to enhance functionality even further.
Described as an adaptable solution to infection, contamination and spoilage in healthcare settings, beneFIT Control has a unique ability to minimize the impact on natural and normal skin flora while maximizing effect on troublesome organisms. Most other antimicrobial technologies are not selective in their function, resulting in all the microbials being killed or limited all the time.
beneFIT Control technology has been designed with the disposable hygiene product specifically in mind. During testing, beneFIT Control has demonstrated multiple advantages in comparison to conventional solutions. Fabrics utilizing the new technology provide a fast response ideal for the short duration of use that hygiene products typically have and retains a bright white appearance desired by consumers.
